Osamu Yano

1.2k total citations
22 papers, 971 citations indexed

About

Osamu Yano is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Osamu Yano has authored 22 papers receiving a total of 971 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Immunology and 7 papers in Oncology. Recurrent topics in Osamu Yano's work include Drug Transport and Resistance Mechanisms (5 papers), RNA Interference and Gene Delivery (5 papers) and Cancer therapeutics and mechanisms (5 papers). Osamu Yano is often cited by papers focused on Drug Transport and Resistance Mechanisms (5 papers), RNA Interference and Gene Delivery (5 papers) and Cancer therapeutics and mechanisms (5 papers). Osamu Yano collaborates with scholars based in Japan, Germany and Armenia. Osamu Yano's co-authors include Tohru Tokunaga, Etsuro Kuramoto, Tetsuro Kataoka, Toshiko Yamamoto, Saburo Yamamoto, Shizuo Shimada, Yoshimitsu Kimura, Takashi Tsuruo, Wakao Sato and Tsuneji Suzuki and has published in prestigious journals such as Nucleic Acids Research, Journal of Medicinal Chemistry and The Journal of Biochemistry.

In The Last Decade

Osamu Yano

22 papers receiving 927 citations

Peers

Countries citing papers authored by Osamu Yano

Since Specialization

Citations

This map shows the geographic impact of Osamu Yano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Osamu Yano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Osamu Yano more than expected).

Fields of papers citing papers by Osamu Yano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Osamu Yano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Osamu Yano. The network helps show where Osamu Yano may publish in the future.

Co-authorship network of co-authors of Osamu Yano

This figure shows the co-authorship network connecting the top 25 collaborators of Osamu Yano. A scholar is included among the top collaborators of Osamu Yano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Osamu Yano. Osamu Yano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A novel quinoline derivative, MS-209, overcomes drug resistance of human lung cancer cells expressing the multidrug resistance-associated protein (MRP) gene 1997 ·Cancer Chemotherapy and Pharmacology ·(unknown), Mikio Oka, Minoru Fukuda, (unknown), Kôki Ikeda, Hiroshi Takatani, Kenji Terashi, Hiroshi Soda, Osamu Yano, Tsuyoshi Nakamura, L. Austin Doyle, Takashi Tsuruo, Shigeru Kohno	29
2	Structure−Activity Relationship of Newly Synthesized Quinoline Derivatives for Reversal of Multidrug Resistance in Cancer 1997 ·Journal of Medicinal Chemistry ·Tsuneji Suzuki, Nobuyuki Fukazawa, (unknown), Wakao Sato, Osamu Yano, Takashi Tsuruo	81
3	Reversal of multidrug resistance by a novel quinoline derivative, MS-209 1995 ·Cancer Chemotherapy and Pharmacology ·Wakao Sato, Nobuyuki Fukazawa, Osamu Nakanishi, Makoto Baba, Tsuneji Suzuki, Osamu Yano, Mikihiko Naito, Takashi Tsuruo	55
4	Relationship between multidrug resistant gene expression and multidrug resistant-reversing ef fect of MS-209 in various tumor cells 1995 ·Cancer Chemotherapy and Pharmacology ·Makoto Baba, Osamu Nakanishi, Wakao Sato, Akiko Saito, (unknown), Osamu Yano, Shizuo Shimada, Nobuyuki Fukazawa, Mikihiko Naito, T. Tsuruo	2
5	Reversal of multidrug resistance by a novel quinoline derivative, MS-209 1995 ·Cancer Chemotherapy and Pharmacology ·Wakao Sato, Nobuyuki Fukazawa, Osamu Nakanishi, Makoto Baba, Tsuneji Suzuki, Osamu Yano, Mikihiko Naito, T. Tsuruo	1
6	Studies on the Constituents of Calliandra anomala (KUNTH) MACBR. I. Structure Elucidation of Two Acylated Triterpenoidal Saponins. 1993 ·Chemical and Pharmaceutical Bulletin ·Tadahiro Takeda, Takatoshi Nakamura, Shigeki Takashima, Osamu Yano, Yukio Ogihara	21
7	Induction of T-cell-mediated immunity against MethA fibrosarcoma by intratumoral injections of a bacillus Calmette-Guérin nucleic acid fraction 1992 ·Cancer Immunology Immunotherapy ·Etsuro Kuramoto, Osamu Yano, Shizuo Shimada	1
8	Oligonucleotide Sequences Required for Natural Killer Cell Activation 1992 ·Japanese Journal of Cancer Research ·Etsuro Kuramoto, Osamu Yano, Yoshimitsu Kimura, Makoto Baba, Tadashi Makino, Saburo Yamamoto, Toshiko Yamamoto, Tetsuro Kataoka, Tohru Tokunaga	95
9	Antitumor Activity of Synthetic Oligonucleotides with Sequences from cDNA Encoding Proteins of Mycobacterium bovis BCG 1992 ·Japanese Journal of Cancer Research ·Tetsuro Kataoka, Saburo Yamamoto, Toshiko Yamamoto, Etsuro Kuramoto, Yoshimitsu Kimura, Osamu Yano, Tohru Tokunaga	40
10	Changes of host cell infiltration into meth a fibrosarcoma tumor during the course of regression induced by injections of a BCG nucleic acid fraction 1992 ·International Journal of Immunopharmacology ·Etsuro Kuramoto, (unknown), (unknown), Osamu Yano, Shizuo Shimada, Tohru Tokunaga	8
11	DNA from Bacteria, but Not from Vertebrates, Induces Interferons, Activates Natural Killer Cells and Inhibits Tumor Growth 1992 ·Microbiology and Immunology ·Saburo Yamamoto, Toshiko Yamamoto, Shizuo Shimada, Etsuro Kuramoto, Osamu Yano, Tetsuro Kataoka, Tohru Tokunaga	302
12	Cloning and sequencing of viral integration site in human fibroblasts immortalized by simian virus 40. 1991 ·Cell Structure and Function ·Osamu Yano, Hideyasu Hirano, Yuji Karasaki, Ken Higashi, Hayato Nakamura, S Akiya, Sadao Gotoh	4
13	Some Properties of Fibroblasts from a Patient with Debrancher Deficiency 1990 ·Journal of UOEH ·(unknown), Osamu Yano, Sadao Gotoh, Ken Higashi, Eiji Hasegawa, Akio Ohnishi	1
14	Two purified factors bind to the same sequence in the enhancer of mouse MHC class I genes: one of them is a positive regulator induced upon differentiation of teratocarcinoma cells 1989 ·Nucleic Acids Research ·Alain Israël, Osamu Yano, (unknown), Mark W. Kieran, Philippe Kourilsky	58
15	The Factors Necessary to Achieve Successful Penetrating Keratoplasty 1987 ·Journal of UOEH ·Osamu Yano, (unknown)	1
16	DEVELOPMENT OF TRAVEL-ACTIVITY SCHEDULING MODEL INCORPORATING CHOICE PROCESSES OF NUMBER, LOCATIONS AND TIME ALLOCATION OF DISCRETIONARY ACTIVITIES 1987 ·INFRASTRUCTURE PLANNING REVIEW ·(unknown), (unknown), Osamu Yano	1
17	In vivo augmentation of natural killer cell activity with a deoxyribonucleic acid fraction of BCG. 1986 ·PubMed ·Shizuo Shimada, Osamu Yano, Tohru Tokunaga	61
18	Properties of TAS‐1D3, a Tuberculin‐Active Substance from BCG, in Regard to Delayed Hypersensitivity 1984 ·Microbiology and Immunology ·Osamu Yano, (unknown), (unknown)	1
19	Purification and Characterization of a Tuberculin-Active Substance from Mycobacterium bovis BCG 1984 ·The Journal of Biochemistry ·Osamu Yano, Tamotsu Fukuda, (unknown), (unknown)	6
20	Purification and biological activities of pokeweed (Phytolacca Americana) mitogens 1976 ·Biochimica et Biophysica Acta (BBA) - Protein Structure ·Kazushige Yokoyama, Osamu Yano, Tadao Terao, Toshiaki Osawa	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact